Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Napolioni, Valerio ^a,b,c   Ober Reynolds, Benjamin ^a   Szelinger, Szabolcs ^a   Corneveaux, Jason J ^a   Pawlowski, Traci ^a,e   Ober Reynolds, Sharman ^d   Kirwan, Janet ^d   Persico, Antonio M ^b,c   Melmed, Raun D ^d   Craig, David W ^a   Smith, Christopher J ^d   Huentelman, Matthew J ^a  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d Southwest Autism Research and Resource Center   (United States)

^e Clinical Molecular Lab   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 7; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BCL; PROTEIN MIP 1DELTA; PROTEIN TNF SRIII; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPHENOTYPE; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL DISEASE; HEAD CIRCUMFERENCE; HUMAN; IMMUNOPHENOTYPING; INTELLIGENCE QUOTIENT; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN POLYMORPHISM; QUANTITATIVE TRAIT; SCHOOL CHILD; SCORING SYSTEM; SOCIAL RESPONSIVENESS SCALE TOTAL T SCORE; UPREGULATION; VINELAND ADAPTIVE BEHAVIOR SCALE IN AUTISM COMPOSITE SCORE;

EID: 84874937105     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-38     Document Type: Article

References (77)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, Washington, DC: American Psychiatric Association, fourth edition, text revision, American Psychiatric Association.
2. Lintas C, Persico AM. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet 2009, 46:1-8. 2603481, 18728070.
3. Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 2006, 29:349-358. 10.1016/j.tins.2006.05.010, 16808981.
4. Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2012, 26:383-392. 10.1016/j.bbi.2011.08.007, 3418145, 21906670.
5. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 1999, 14:388-394. 10.1177/088307389901400608, 10385847.
6. Enstrom AM, Lit L, Onore CE, Gregg JP, Hansen RL, Pessah IN, Hertz-Picciotto I, Van de Water JA, Sharp FR, Ashwood P. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun 2009, 23:124-133. 10.1016/j.bbi.2008.08.001, 2636576, 18762240.
7. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, Persico AM. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 2008, 30:303-311. 10.1016/j.nbd.2008.01.012, 2693090, 18378158.
8. Goines P, Haapanen L, Boyce R, Duncanson P, Braunschweig D, Delwiche L, Hansen R, Hertz-Picciotto I, Ashwood P, Van de Water J. Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun 2011, 25:514-523. 10.1016/j.bbi.2010.11.017, 3039058, 21134442.
9. Mostafa GA, Al-Ayadhi LY. A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children. J Neuroinflammation 2011, 8:71. 10.1186/1742-2094-8-71, 3142225, 21696608.
10. Mostafa GA, El-Sayed ZA, El-Aziz MM, El-Sayed MF. Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J Child Neurol 2008, 23:1413-1418. 10.1177/0883073808319321, 19073846.
11. Mostafa GA, Al-Ayadhi LY. Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J Neuroinflammation 2011, 8:39. 10.1186/1742-2094-8-39, 3104945, 21513576.
12. Mostafa GA, Al-Ayadhi LY. The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children. Eur J Paediatr Neurol 2012, 16:464-468. 10.1016/j.ejpn.2011.12.010, 22226851.
13. Zhang B, Angelidou A, Alysandratos KD, Vasiadi M, Francis K, Asadi S, Theoharides A, Sideri K, Lykouras L, Kalogeromitros D, Theoharides TC. Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children. J Neuroinflammation 2010, 7:80. 10.1186/1742-2094-7-80, 3001695, 21083929.
14. Corbett BA, Kantor AB, Schulman H, Walker WL, Lit L, Ashwood P, Rocke DM, Sharp FR. A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol Psychiatry 2007, 12:292-306.
15. Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 2002, 45:1-6.
16. Croonenberghs J, Wauters A, Devreese K, Verkerk R, Scharpe S, Bosmans E, Egyed B, Deboutte D, Maes M. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med 2002, 32:1457-1463.
17. Schwarz E, Guest PC, Rahmoune H, Wang L, Levin Y, Ingudomnukul E, Ruta L, Kent L, Spain M, Baron-Cohen S, Bahn S. Sex-specific serum biomarker patterns in adults with Asperger's syndrome. Mol Psychiatry 2011, 16:1213-1220. 10.1038/mp.2010.102, 20877284.
18. Singh VK, Warren RP, Odell JD, Cole P. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin Immunol Immunopathol 1991, 61:448-455. 10.1016/S0090-1229(05)80015-7, 1934632.
19. Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstien S, Varsou A, Heyes MP. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 2005, 33:195-201. 10.1016/j.pediatrneurol.2005.03.014, 16139734.
20. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2011, 25:40-45. 10.1016/j.bbi.2010.08.003, 2991432, 20705131.
21. Onore C, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen R, Van de Water J, Ashwood P. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J Neuroimmunol 2009, 216:126-129. 10.1016/j.jneuroim.2009.09.005, 2981175, 19800697.
22. Grigorenko EL, Han SS, Yrigollen CM, Leng L, Mizue Y, Anderson GM, Mulder EJ, de Bildt A, Minderaa RB, Volkmar FR, Chang JT, Bucala R. Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 2008, 122:e438-e445. 10.1542/peds.2007-3604, 18676531.
23. Singh VK. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 1996, 66:143-145. 10.1016/0165-5728(96)00014-8, 8964908.
24. Sweeten TL, Posey DJ, Shankar S, McDougle CJ. High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry 2004, 55:434-437. 10.1016/j.biopsych.2003.09.001, 14960298.
25. Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, Yoshihara Y, Wakuda T, Takebayashi K, Takagai S, Matsumoto K, Tsuchiya KJ, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Mori N. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 2011, 6:e20470. 10.1371/journal.pone.0020470, 3103577, 21647375.
26. Angelidou A, Francis K, Vasiadi M, Alysandratos KD, Zhang B, Theoharides A, Lykouras L, Sideri K, Kalogeromitros D, Theoharides TC. Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation 2010, 7:48. 10.1186/1742-2094-7-48, 2936302, 20731814.
27. Boucher J. Research review: structural language in autistic spectrum disorder - characteristics and causes. J Child Psychol Psychiatry 2012, 53:219-233. 10.1111/j.1469-7610.2011.02508.x, 22188468.
28. Stefanatos GA. Regression in autistic spectrum disorders. Neuropsychol Rev 2008, 18:305-319. 10.1007/s11065-008-9073-y, 18956241.
29. Buie T, Campbell DB, Fuchs GJ, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL, Carr EG, Gershon MD, Hyman SL, Jirapinyo P, Jyonouchi H, Kooros K, Kushak R, Levitt P, Levy SE, Lewis JD, Murray KF, Natowicz MR, Sabra A, Wershil BK, Weston SC, Zeltzer L, Winter H. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 2010, 125:S1-S18. 10.1542/peds.2009-1878C, 20048083.
30. Theoharides TC, Angelidou A, Alysandratos KD, Zhang B, Asadi S, Francis K, Toniato E, Kalogeromitros D. Mast cell activation and autism. Biochim Biophys Acta 2012, 1822:34-41. 10.1016/j.bbadis.2010.12.017, 21193035.
31. Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, DiLavore PC, Pickles A, Rutter M. The Autism Diagnostic Observation Schedule-Generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000, 30:205-223. 10.1023/A:1005592401947, 11055457.
32. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994, 24:659-685. 10.1007/BF02172145, 7814313.
33. Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, Metzger LM, Shoushtari CS, Splinter R, Reich W. Validation of a brief quantitative measure of autistic traits: comparison of the Social Responsiveness Scale with the Autism Diagnostic Interview-Revised. J Autism Dev Disord 2003, 33:427-433. 10.1023/A:1025014929212, 12959421.
34. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46. 10.1097/00001648-199001000-00010, 2081237.
35. Pernerger TV. What's wrong with Bonferroni adjustments?. BMJ 1998, 316:1236-1238. 10.1136/bmj.316.7139.1236, 1112991, 9553006.
36. Sacco R, Militerni R, Frolli A, Bravaccio C, Gritti A, Elia M, Curatolo P, Manzi B, Trillo S, Lenti C, Saccani M, Schneider C, Melmed R, Reichelt KL, Pascucci T, Puglisi-Allegra S, Persico AM. Clinical, morphological, and biochemical correlates of head circumference in autism. Biol Psychiatry 2007, 62:1038-1047. 10.1016/j.biopsych.2007.04.039, 17644070.
37. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008, 9:341-355. 10.1038/nrg2346, 2756414, 18414403.
38. Saresella M, Marventano I, Guerini FR, Mancuso R, Ceresa L, Zanzottera M, Rusconi B, Maggioni E, Tinelli C, Clerici M. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry 2009, 66:978-984. 10.1016/j.biopsych.2009.06.020, 19699471.
39. Singer HS, Morris CM, Williams PN, Yoon DY, Hong JJ, Zimmerman AW. Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol 2006, 178:149-155. 10.1016/j.jneuroim.2006.05.025, 16842863.
40. Constantino JN, Lajonchere C, Lutz M, Gray T, Abbacchi A, McKenna K, Singh D, Todd RD. Autistic social impairment in the siblings of children with pervasive developmental disorders. Am J Psychiatry 2006, 163:294-296. 10.1176/appi.ajp.163.2.294, 16449484.
41. Constantino JN, Todd RD. Intergenerational transmission of subthreshold autistic traits in the general population. Biol Psychiatry 2005, 57:655-660. 10.1016/j.biopsych.2004.12.014, 15780853.
42. Alarcón M, Yonan AL, Gilliam TC, Cantor RM, Geschwind DH. Quantitative genome scan and ordered-subsets analysis of autism endophenotypes support language QTLs. Mol Psychiatry 2005, 10:747-757. 10.1038/sj.mp.4001666, 15824743.
43. Yirmiya N, Ozonoff S. The very early autism phenotype. J Autism Dev Disord 2007, 37:1-11.
44. Orsmond GI, Seltzer MM. Siblings of individuals with autism spectrum disorders across the life course. Ment Retard Dev Disabil Res Rev 2007, 13:313-320. 10.1002/mrdd.20171, 17979200.
45. Robinson EB, Koenen KC, McCormick MC, Munir K, Hallett V, Happé F, Plomin R, Ronald A. Evidence that autistic traits show the same etiology in the general population and at the quantitative extremes (5%, 2.5%, and 1%). Arch Gen Psychiatry 2011, 68:1113-1121. 10.1001/archgenpsychiatry.2011.119, 22065527.
46. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, Miller J, Fedele A, Collins J, Smith K, Lotspeich L, Croen LA, Ozonoff S, Lajonchere C, Grether JK, Risch N. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011, 68:1095-1102. 10.1001/archgenpsychiatry.2011.76, 21727249.
47. Nellhaus G. Head circumference from birth to eighteen years: practical composite international and interracial graphs. Pediatrics 1968, 41:106-114.
48. Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment. Neurotoxicol Teratol 2012, http://dx.doi.org/10.1016/j.ntt.2012.07.006.
49. Ashwood P, Kwong C, Hansen R, Hertz-Picciotto I, Croen L, Krakowiak P, Walker W, Pessah IN, Van de Water J. Plasma leptin levels are elevated in autism: association with early onset phenotype?. J Autism Dev Disord 2008, 38:169-175. 10.1007/s10803-006-0353-1, 17347881.
50. Bu B, Ashwood P, Harvey D, King IB, Van de Water J, Jin LW. Fatty acid composition of red blood cell phospholipids in children with autism. Prostaglandins Leukot Essent Fatty Acids 2006, 74:215-221. 10.1016/j.plefa.2006.02.001, 16581239.
51. Enstrom A, Onore C, Hertz-Picciotto I, Hansen R, Croen L, Van de Water J, Ashwood P. Detection of IL-17 and IL-23 in plasma samples of children with autism. Am J Biochem Biotechnol 2008, 4:114-120.
52. Enstrom A, Onore C, Tarver A, Hertz-Picciotto I, Hansen R, Croen L, Van de Water J, Ashwood P. Peripheral blood leukocyte production of BDNF following mitogen stimulation in early onset and regressive autism. Am J Biochem Biotechnol 2008, 4:121-129.
53. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R, Kharrazi M, Ashwood P, Van de Water J. Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism 2011, 2:13. 10.1186/2040-2392-2-13, 3170586, 21810230.
54. Chiba N, Masuda A, Yoshikai Y, Matsuguchi T. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells. J Cell Physiol 2007, 213:126-136. 10.1002/jcp.21101, 17458900.
55. Takatsu K, Kouro T, Nagai Y. Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol 2009, 101:191-236.
56. Braunschweig D, Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA, Pessah IN, Van de Water J. Autism: Maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 2008, 29:226-231. 2305723, 18078998.
57. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 2011, 232:196-199. 10.1016/j.jneuroim.2010.10.025, 3053074, 21095018.
58. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57:67-81. 10.1002/ana.20315, 15546155.
59. An Y, Chen Q, Quan N. Interleukin-1 exerts distinct actions on different cell types of the brain in vitro. J Inflamm Res 2011, 2011:11-20. 3196613,3196613, 22022205.
60. Wei H, Zou H, Sheikh AM, Malik M, Dobkin C, Brown WT, Li X. IL-6 is increased in the cerebellum of brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflammation 2011, 8:52. 10.1186/1742-2094-8-52, 3114764, 21595886.
61. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007, 27:10695-10702. 10.1523/JNEUROSCI.2178-07.2007, 2387067, 17913903.
62. Pérez-Martínez L, Jaworski DM. Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J Neurosci 2005, 25:4917-4929. 10.1523/JNEUROSCI.5066-04.2005, 1282460, 15901773.
63. Luther SA, Ansel KM, Cyster JG. Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J Exp Med 2003, 197:1191-1198. 10.1084/jem.20021294, 2193976, 12732660.
64. Michaelson MD, Mehler MF, Xu H, Gross RE, Kessler JA. Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. Dev Biol 1996, 179:251-263. 10.1006/dbio.1996.0255, 8873768.
65. Huang YS, Cheng SN, Chueh SH, Tsai YL, Liou NH, Guo YW, Liao MH, Shen LH, Chen CC, Liu JC, Ma KH. Effects of interleukin-15 on neuronal differentiation of neural stem cells. Brain Res 2009, 1304:38-48.
66. Fujita E, Tanabe Y, Shiota A, Ueda M, Suwa K, Momoi MY, Momoi T. Ultrasonic vocalization impairment of Foxp2 (R552H) knockin mice related to speech-language disorder and abnormality of Purkinje cells. Proc Natl Acad Sci U S A 2008, 105:3117-3122. 10.1073/pnas.0712298105, 2268594, 18287060.
67. Krieger M, Both M, Kranig SA, Pitzer C, Klugmann M, Vogt G, Draguhn A, Schneider A. The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions. Sci Rep 2012, 2:697. 3458247, 23019518.
68. Bender AT, Beavo JA. Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages. Neurochem Int 2004, 45:853-857. 10.1016/j.neuint.2004.03.015, 15312979.
69. Hashimoto SI, Komuro I, Yamada M, Akagawa KS. IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages. J Immunol 2001, 167:3619-3625.
70. Takasugi K, Yamamura M, Iwahashi M, Otsuka F, Yamana J, Sunahori K, Kawashima M, Yamada M, Makino H. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis. Arthritis Res Ther 2006, 8:R126.40.
71. Persico AM, Napolioni V. Urinary p-cresol in autism spectrum disorder. Neurotoxicol Teratol 2012,.
72. Brynskov J, Tvede N, Andersen CB, Vilien M. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992, 33:55-58. 10.1136/gut.33.1.55, 1373865, 1740278.
73. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S. Cytokine production in patients with inflammatory bowel disease. Gut 1992, 33:933-937. 10.1136/gut.33.7.933, 1379407, 1644332.
74. Musso T, Espinoza-Delgado I, Pulkki K, Gusella GL, Longo DL, Varesio L. IL-2 induces IL-6 production in human monocytes. J Immunol 1992, 148:795-800.
75. Master SR, Bierl C, Kricka LJ. Diagnostic challenges for multiplexed protein microarrays. Drug Discov Today 2006, 11:1007-1011. 10.1016/j.drudis.2006.09.010, 17055410.
76. Sanchez-Carbayo M. Antibody arrays: technical considerations and clinical applications in cancer. Clin Chem 2006, 52:1651-1659. 10.1373/clinchem.2005.059592, 16809399.
77. Litteljohn D, Hayley S. Cytokines as potential biomarkers for Parkinson's disease: a multiplex approach. Methods Mol Biol 2012, 934:121-144. 10.1007/978-1-62703-071-7_7, 22933144.